• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症干细胞与上皮-间充质转化的相关性:分子机制及其在癌症治疗中的意义。

The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis.

机构信息

Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, New York, NY, United States.

出版信息

Front Immunol. 2024 Sep 30;15:1417201. doi: 10.3389/fimmu.2024.1417201. eCollection 2024.

DOI:10.3389/fimmu.2024.1417201
PMID:39403386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11471544/
Abstract

The connections between cancer stem cells (CSCs) and epithelial-mesenchymal transition (EMT) is critical in cancer initiation, progression, metastasis, and therapy resistance, making it a focal point in cancer theragnosis. This review provides a panorama of associations and regulation pathways between CSCs and EMT, highlighting their significance in cancer. The molecular mechanisms underlined EMT are thoroughly explored, including the involvement of key transcription factors and signaling pathways. In addition, the roles of CSCs and EMT in tumor biology and therapy resistance, is further examined in this review. The clinical implications of CSCs-EMT interplay are explored, including identifying mesenchymal-state CSC subpopulations using advanced research methods and developing targeted therapies such as inhibitors and combination treatments. Overall, understanding the reciprocal relationship between EMT and CSCs holds excellent potential for informing the development of personalized therapies and ultimately improving patient outcomes.

摘要

癌症干细胞 (CSCs) 与上皮-间充质转化 (EMT) 之间的联系在癌症的发生、进展、转移和治疗耐药中至关重要,使其成为癌症治疗学的重点。本综述提供了 CSCs 与 EMT 之间关联和调控途径的全景图,强调了它们在癌症中的重要性。深入探讨了 EMT 所涉及的分子机制,包括关键转录因子和信号通路的参与。此外,本综述还进一步研究了 CSCs 和 EMT 在肿瘤生物学和治疗耐药性中的作用。探讨了 CSCs-EMT 相互作用的临床意义,包括使用先进的研究方法识别间充质状态 CSC 亚群以及开发靶向治疗方法,如抑制剂和联合治疗。总的来说,理解 EMT 和 CSCs 之间的相互关系具有为制定个性化治疗方案提供信息的巨大潜力,并最终改善患者的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5b5/11471544/311fe83442a5/fimmu-15-1417201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5b5/11471544/768a5477b2f7/fimmu-15-1417201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5b5/11471544/311fe83442a5/fimmu-15-1417201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5b5/11471544/768a5477b2f7/fimmu-15-1417201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5b5/11471544/311fe83442a5/fimmu-15-1417201-g002.jpg

相似文献

1
The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis.癌症干细胞与上皮-间充质转化的相关性:分子机制及其在癌症治疗中的意义。
Front Immunol. 2024 Sep 30;15:1417201. doi: 10.3389/fimmu.2024.1417201. eCollection 2024.
2
Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.JAK/STAT3信号通路在上皮-间质转化调控肿瘤转移、癌症干细胞转变及肿瘤化疗耐药中的作用
Cells. 2020 Jan 15;9(1):217. doi: 10.3390/cells9010217.
3
The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.上皮-间质转化与癌症干细胞:功能及机制联系
Curr Pharm Des. 2015;21(10):1279-91. doi: 10.2174/1381612821666141211115611.
4
EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.表皮生长因子受体(EGFR)抑制剂通过抑制上皮-间质转化来阻止食管鳞状细胞癌中癌症干细胞样细胞的诱导。
Cancer Biol Ther. 2015;16(6):933-40. doi: 10.1080/15384047.2015.1040959. Epub 2015 Apr 21.
5
The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.河马信号转导蛋白TAZ促进口腔癌中的上皮-间质转化和癌症干细胞维持。
Mol Oncol. 2015 Jun;9(6):1091-105. doi: 10.1016/j.molonc.2015.01.007. Epub 2015 Feb 9.
6
Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets.简要综述:癌症中的干细胞与上皮-间质转化:生物学意义及治疗靶点
Stem Cells. 2016 Aug;34(8):1997-2007. doi: 10.1002/stem.2406. Epub 2016 Jun 20.
7
Stem cell programs in cancer initiation, progression, and therapy resistance.肿瘤起始、进展和治疗抵抗中的干细胞程序。
Theranostics. 2020 Jul 9;10(19):8721-8743. doi: 10.7150/thno.41648. eCollection 2020.
8
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.靶向上皮-间质转化(EMT)以克服癌症中的耐药性
Molecules. 2016 Jul 22;21(7):965. doi: 10.3390/molecules21070965.
9
Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer.上皮-间质转化和癌症干细胞在前列腺癌去势抵抗发展中的作用。
Mol Cancer. 2014 Mar 12;13:55. doi: 10.1186/1476-4598-13-55.
10
Epithelial-Mesenchymal Transition and Cancer Stem Cells.上皮-间质转化与癌症干细胞
Adv Exp Med Biol. 2022;1393:1-49. doi: 10.1007/978-3-031-12974-2_1.

引用本文的文献

1
Notch3 mediated TGF‑β1 activation enhances epithelial‑mesenchymal transition and cancer stemness in non‑small lung cancer.Notch3介导的TGF-β1激活增强非小细胞肺癌中的上皮-间质转化和癌症干性。
Int J Oncol. 2025 Oct;67(4). doi: 10.3892/ijo.2025.5791. Epub 2025 Aug 24.
2
Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities.个性化治疗中的癌症干细胞:机制、微环境相互作用及治疗弱点
Front Cell Dev Biol. 2025 Jul 30;13:1619597. doi: 10.3389/fcell.2025.1619597. eCollection 2025.
3
Microenvironment and Tumor Heterogeneity as Pharmacological Targets in Precision Oncology.

本文引用的文献

1
Multi-omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple-negative breast cancer.二硫键连接的细胞焦亡调节因子的多组学分析及治疗潜力揭示糖原合酶1是三阴性乳腺癌二硫键连接的细胞焦亡触发靶点。
MedComm (2020). 2024 Feb 28;5(3):e502. doi: 10.1002/mco2.502. eCollection 2024 Mar.
2
Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer.GPRC5A 甲基化通过激活三阴性乳腺癌中的 mTOR 信号通路促进肝转移和多西紫杉醇耐药。
Drug Resist Updat. 2024 Mar;73:101063. doi: 10.1016/j.drup.2024.101063. Epub 2024 Feb 1.
3
微环境与肿瘤异质性作为精准肿瘤学中的药理学靶点
Pharmaceuticals (Basel). 2025 Jun 18;18(6):915. doi: 10.3390/ph18060915.
4
27-Hydroxycholesterol in cancer development and drug resistance.27-羟基胆固醇在癌症发生发展及耐药性中的作用
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2507670. doi: 10.1080/14756366.2025.2507670. Epub 2025 May 22.
5
From Defense to Disease: How the Immune System Fuels Epithelial-Mesenchymal Transition in Ovarian Cancer.从防御到疾病:免疫系统如何助力卵巢癌中的上皮-间质转化
Int J Mol Sci. 2025 Apr 24;26(9):4041. doi: 10.3390/ijms26094041.
6
Functional Characterization of miR-216a-5p and miR-125a-5p on Pancreatic Cancer Stem Cells.miR-216a-5p和miR-125a-5p对胰腺癌干细胞的功能表征
Int J Mol Sci. 2025 Mar 21;26(7):2830. doi: 10.3390/ijms26072830.
7
Exposing the cellular situation: findings from single cell RNA sequencing in breast cancer.揭示细胞状况:乳腺癌单细胞RNA测序的研究结果
Front Immunol. 2025 Mar 6;16:1539074. doi: 10.3389/fimmu.2025.1539074. eCollection 2025.
8
Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies.解读癌症干细胞的作用:肿瘤进化、治疗抗性及精准医学策略的驱动因素
Cancers (Basel). 2025 Jan 24;17(3):382. doi: 10.3390/cancers17030382.
9
Effect of β-catenin on hypoxia induced epithelial mesenchymal transition in HK-2 cells by regulating Brachyury.β-连环蛋白通过调控短尾蛋白对缺氧诱导的HK-2细胞上皮间质转化的影响
Biochem Biophys Rep. 2024 Dec 26;41:101907. doi: 10.1016/j.bbrep.2024.101907. eCollection 2025 Mar.
Ubenimex suppresses glycolysis mediated by CD13/Hedgehog signaling to enhance the effect of cisplatin in liver cancer.
乌苯美司通过抑制CD13/刺猬信号通路介导的糖酵解来增强顺铂对肝癌的治疗效果。
Transl Cancer Res. 2023 Oct 31;12(10):2823-2836. doi: 10.21037/tcr-23-435. Epub 2023 Sep 28.
4
CD133-Targeted Hybrid Nanovesicles for Fluorescent/Ultrasonic Imaging-Guided HIFU Pancreatic Cancer Therapy.CD133 靶向杂化纳米囊泡用于荧光/超声成像引导的高强度聚焦超声胰腺癌治疗。
Int J Nanomedicine. 2023 May 12;18:2539-2552. doi: 10.2147/IJN.S391382. eCollection 2023.
5
Recent advances in aptamer-based therapeutic strategies for targeting cancer stem cells.基于适配体的癌症干细胞靶向治疗策略的最新进展。
Mater Today Bio. 2023 Mar 11;19:100605. doi: 10.1016/j.mtbio.2023.100605. eCollection 2023 Apr.
6
ABC Transporters and CYP3A4 Mediate Drug Interactions between Enrofloxacin and Salinomycin Leading to Increased Risk of Drug Residues and Resistance.ABC转运蛋白和CYP3A4介导恩诺沙星和盐霉素之间的药物相互作用,导致药物残留和耐药性风险增加。
Antibiotics (Basel). 2023 Feb 17;12(2):403. doi: 10.3390/antibiotics12020403.
7
Development of Tc-Hynic-Adh-1 Molecular Probe Specifically Targeting N-Cadherin and Its Preliminary Experimental Study in Monitoring Drug Resistance of Non-Small-Cell Lung Cancer.靶向N-钙黏蛋白的锝[Tc]标记海因衍生物-1分子探针的研制及其监测非小细胞肺癌耐药性的初步实验研究
Cancers (Basel). 2023 Jan 26;15(3):755. doi: 10.3390/cancers15030755.
8
N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.N6-甲基腺苷介导的 FZD10 上调通过 WNT/β-连环蛋白和 Hippo 信号通路调节肝癌干细胞特性和仑伐替尼耐药性。
Gastroenterology. 2023 May;164(6):990-1005. doi: 10.1053/j.gastro.2023.01.041. Epub 2023 Feb 8.
9
Cell signaling and regulation of CFTR expression in cystic fibrosis cells in the era of high efficiency modulator therapy.在高效调节剂治疗时代囊性纤维化细胞中 CFTR 的细胞信号传导和调控。
J Cyst Fibros. 2023 Mar;22 Suppl 1:S12-S16. doi: 10.1016/j.jcf.2022.12.015. Epub 2023 Jan 7.
10
PD-L1 upregulation promotes drug-induced pulmonary fibrosis by inhibiting vimentin degradation.程序性死亡受体配体1(PD-L1)上调通过抑制波形蛋白降解促进药物诱导的肺纤维化。
Pharmacol Res. 2023 Jan;187:106636. doi: 10.1016/j.phrs.2022.106636. Epub 2022 Dec 28.